
Panacea Biotec Q2 FY27 Results: Consolidated Net Profit ₹11.91 Crore on Total Income of ₹196 Crore
Panacea Biotec (NSE: PANACEABIO) reported consolidated total income of ₹196 crore and net profit of ₹12 crore for the quarter ended 30 Sep 2026; standalone total income was ₹133 crore and net profit ₹11 crore. The company said in a filing on 14 Nov 2026 that its board approved the unaudited results.
- Earnings
- pharmaceuticals and vaccines